Salud Santos
Biographic Data
| ID | 7921631 |
|---|---|
| NAME | Salud Santos |
| GIVEN NAMES | Salud |
| FAMILY NAME | Santos |
| SIGNATURE | SANTOS S |
| AFFILIATIONS | Bellvitge University Hospital |
| ORCID | 0000-0002-5835-1028 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
Outcomes of Covid-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol
The intermediate respiratory care units (IRCUs) have a pivotal role managing escalation and de-escalation between the general wards and the intensive care units (ICUs). Since the COVID-19 pandemic began, the early detection of patients that could improve on non-invasive respiratory therapies (NRTs) in IRCUs without invasive approaches is crucial to ensure proper medical management and optimize limiting ICU resources. The aim of this study was to …
No prominent works on this page.
Outcomes of Covid-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol
The intermediate respiratory care units (IRCUs) have a pivotal role managing escalation and de-escalation between the general wards and the intensive care units (ICUs). Since the COVID-19 pandemic began, the early detection of patients that could improve on non-invasive respiratory therapies (NRTs) in IRCUs without invasive approaches is crucial to ensure proper medical management and optimize limiting ICU resources. The aim of this study was to …
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
Long-Term Effects of COVID-19 (2 works) · Anesthesia (1 works) · Coronavirus (1 works) · Disease (1 works) · Emergency Medicine (1 works) · Gut flora (1 works) · Gut microbiome (1 works) · Gut microbiota and health (1 works) · Immune responses and vaccinations (1 works) · Intensive care (1 works)